Elevance Health, Inc.
AT ˙ WBAG
SecurityAT:ELV / Elevance Health, Inc.
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership52,537 shares
Latest Disclosed Value $ 15,380,482
Crossmark Global Holdings, Inc. reports 5.16% decrease in ownership of ELV / Elevance Health, Inc.

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 52,537 shares of Elevance Health, Inc. (AT:ELV) valued at $15,380,482 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 55,394 shares of Elevance Health, Inc.. This represents a change in shares of -5.16% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 52,537 -2,857 -5.16 15,380 -20.80 0.2246
2026-02-03 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 55,394 3,392 6.52 19,419 15.57 0.2770
2025-11-12 2025-09-30 13F ELEVANCE HEALTH COM 036752103 52,002 -1,503 -2.81 16,803 -19.26 0.2517
2025-08-08 2025-06-30 13F ELEVANCE HEALTH COM 036752103 53,505 31,802 146.53 20,811 120.48 0.3360
2025-04-30 2025-03-31 13F ELEVANCE HEALTH COM 036752103 21,703 -112 -0.51 9,440 117,887.50 0.1665
2025-01-16 2024-12-31 13F ELEVANCE HEALTH COM 036752103 21,815 -669 -2.98 8 -27.27 0.1467
2024-11-04 2024-09-30 13F ELEVANCE HEALTH COM 036752103 22,484 -16,261 -41.97 12 -45.00 0.2085
2024-07-29 2024-06-30 13F ELEVANCE HEALTH COM 036752103 38,745 -9,553 -19.78 21 -20.00 0.4013
2024-05-13 2024-03-31 13F ELEVANCE HEALTH COM 036752103 48,298 -1,957 -3.89 25 8.70 0.4801
2024-02-13 2023-12-31 13F ELEVANCE HEALTH COM 036752103 50,255 427 0.86 24 4.55 0.4917
2023-11-08 2023-09-30 13F ELEVANCE HEALTH COM 036752103 49,828 -23,402 -31.96 23 -35.29 0.5141
2023-07-31 2023-06-30 13F ELEVANCE HEALTH COM 036752103 73,230 1,630 2.28 34 6.25 0.7359
2023-05-12 2023-03-31 13F ELEVANCE HEALTH COM 036752103 71,600 24,219 51.12 33 33.33 0.7747
2023-01-19 2022-12-31 13F ELEVANCE HEALTH COM 036752103 47,381 1,748 3.83 24 -99.88 0.6058
2022-11-01 2022-09-30 13F ELEVANCE HEALTH COM 036752103 45,633 787 1.75 20,729 -4.22 0.5752
2022-07-29 2022-06-30 13F ANTHEM INC COM COM 036752103 44,846 3,572 8.65 21,642 6.74 0.5608
2022-05-11 2022-03-31 13F ANTHEM INC COM COM 036752103 41,274 9,189 28.64 20,275 36.32 0.4521
2022-01-10 2021-12-31 13F ANTHEM INC COM COM 036752103 32,085 -3,304 -9.34 14,873 12.73 0.3230
2021-10-21 2021-09-30 13F/A-1 ANTHEM INC COM COM 036752103 35,389 10,901 44.52 13,193 41.10 0.3091
2021-07-21 2021-06-30 13F ANTHEM INC COM COM 036752103 24,488 2,081 9.29 9,350 16.25 0.2199
2021-04-15 2021-03-31 13F ANTHEM INC COM COM 036752103 22,407 -1,483 -6.21 8,043 4.85 0.1992
2021-01-14 2020-12-31 13F ANTHEM INC COM COM 036752103 23,890 -2,874 -10.74 7,671 6.70 0.1940
2020-10-08 2020-09-30 13F ANTHEM INC COM COM 036752103 26,764 2,629 10.89 7,189 13.27 0.2016
2020-08-14 2020-06-30 13F ANTHEM INC COM COM 036752103 24,135 2,503 11.57 6,347 29.24 0.1851
2020-04-28 2020-03-31 13F ANTHEM INC COM COM 036752103 21,632 1,041 5.06 4,911 -21.03 0.1757
2020-02-06 2019-12-31 13F ANTHEM INC COM COM 036752103 20,591 -328 -1.57 6,219 23.81 0.1708
2019-10-09 2019-09-30 13F ANTHEM INC COM COM 036752103 20,919 397 1.93 5,023 -13.28 0.1466
2019-07-09 2019-06-30 13F ANTHEM INC COM COM 036752103 20,522 1,470 7.72 5,792 5.93 0.1624
2019-05-02 2019-03-31 13F ANTHEM INC COM COM 036752103 19,052 -2,071 -9.80 5,468 -1.44 0.1552
2019-01-31 2018-12-31 13F ANTHEM INC COM COM 036752103 21,123 -907 -4.12 5,548 -8.10 0.1720
2018-11-08 2018-09-30 13F/A-1 ANTHEM INC COM COM 036752103 22,030 -671 -2.96 6,037 11.71 0.1532
2018-11-06 2018-09-30 13F ANTHEM INC COM COM 036752103 22,701 0 5,404
2018-07-31 2018-06-30 13F ANTHEM INC COM COM 036752103 22,701 -666 -2.85 5,404 5.26 0.1450
2018-04-16 2018-03-31 13F ANTHEM INC COM COM 036752103 23,367 -1,592 -6.38 5,134 -8.58 0.1327
2018-02-05 2017-12-31 13F ANTHEM INC COM COM 036752103 24,959 -9,147 -26.82 5,616 -13.28 0.1349
2017-10-27 2017-09-30 13F ANTHEM INC COM COM 036752103 34,106 0 0.00 6,476 0.00 0.1669
2017-10-25 2016-09-30 13F ANTHEM INC COM COM 036752103 34,106 34,106 6,476 0.1669
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.